Why is L'Oréal's PR window so critical amid the controversy over its chemical hair-straightening products being linked to cancer?

According to L'Oréal’s latest 2026 financial report, its Luxury Products Division achieved global sales of €7.997 billion, growing by 5.1%—twice the growth rate of the global premium beauty market. In particular, the Chinese market delivered double-digit growth, outperforming the local beauty market by nearly threefold. By September, Tianyancha (a Chinese corporate information platform) showed that L'Oréal further strengthened its position by having its investment fund acquire a stake in Di Luowei—a top-selling makeup brand on Douyin (China’s TikTok). This follows last year’s investments in FIRST COVER, Lin Qingxuan, Wen Xian, and Guan Xia—progressively narrowing L'Oréal’s strategic gaps in China. Just as industry insiders were applauding L'Oréal’s swift turnaround—praising the ‘elephant’s agility’—across the Pacific Ocean, the company faced far rougher waters in the United States, where a government-led legal action was quietly looming. On September 11, 2026, the Arizona Attorney General formally filed a lawsuit in state court, accusing L'Oréal USA, L'Oréal Group, and SoftSheen-Carson of long concealing the carcinogenic risks associated with their chemical hair-straightening products—violating consumer protection laws. L'Oréal denied the allegations, stating its products have undergone rigorous safety assessments. While expanding and thriving in the domestic market, the company simultaneously faces litigation and controversy overseas—a classic 'fire-and-ice' scenario. Though such divergent regulatory and reputational challenges are common for global giants due to regional policy differences, this case strikes at consumers’ most sensitive nerve: health and safety. Its broad demographic impact and high media virality place extraordinary pressure on the company’s ability to balance legal risk against brand reputation. // Over 10,000 lawsuits accumulated over six years—a lingering 'cold case' Arizona’s lawsuit centers on L'Oréal’s chemical hair-straightening products, which allegedly contain formaldehyde-releasing ingredients. Long-term use may increase women’s risk of ovarian and uterine cancers—but the company reportedly failed for decades to clearly warn consumers of this danger. The complaint specifically highlights that the core user group comprises Black American women. It alleges L'Oréal exploited societal aesthetic pressures on this community, aggressively marketing these products despite knowing their potential health hazards—placing profit above consumer safety. The state’s demands are unequivocal: (1) impose fines and award compensation under consumer protection law; and (2) seek a court injunction requiring L'Oréal either to prominently label its products with clear cancer-risk warnings—or cease selling them altogether. Notably, before this official suit, thousands of civil lawsuits had already accumulated over several years. As early as 2022, a U.S. National Institutes of Health (NIH) study found that women who used such chemical straighteners multiple times per year faced more than double the cancer risk compared to non-users. Soon after, affected women in the U.S. began filing lawsuits, claiming they developed cancer after prolonged use of L'Oréal’s straightening products—and alleging product defects and inadequate risk disclosure. As similar cases multiplied, around 2023, U.S. federal courts consolidated these geographically scattered lawsuits into a Multidistrict Litigation (MDL), centralized for efficiency under the U.S. District Court for the Northern District of Illinois, Chicago.

L'Oréal: The Global Winning Formula of a Beauty-Tech Dominator

According to Jacob’s Column’s deep deconstruction of the 'industry’s No. 1 brand' business model, L'Oréal’s firm grip on the global beauty throne—with annual revenue of €43.48 billion—stems from its successful foundational transformation: from a traditional cosmetic chemistry company into a true 'Beauty Tech' dominator. Amid macroeconomic volatility, consumer segmentation, and the robust rise of China’s homegrown C-beauty brands, L'Oréal has demonstrated exceptional resilience. Its 'Winning Pattern' is a precisely interlocking system, distilled into four core pillars: I. Deep Deconstruction of L'Oréal’s Winning Pattern 1. Strategic Downward Disruption: Transitioning from 'One-Size-Fits-All' to 'Beauty for Each' via Beauty Tech & Green Sciences L'Oréal treats technology as its deepest competitive moat. It no longer simply sells beauty products—it delivers data-driven 'solutions'. · A massive digital and scientific foundation: L'Oréal maintains the world’s largest beauty database (exceeding 14,500 TB), employs over 8,000 digital and data specialists plus 4,000 scientists, invests more than €1.3 billion annually in Research & Innovation (R&I), and registered 694 patents in 2024. · Absolute dominance in core ingredients: To counter domestic Chinese brands’ price-driven competition on conventional actives, L'Oréal erects 'downward disruption' barriers through proprietary patented molecules—such as Melasyl™, an anti-hyperpigmentation breakthrough developed over 18 years, and Pro-Xylane, its continuously refined anti-aging flagship ingredient—creating scientific depth and technological barriers virtually insurmountable for local startups. · Smart hardware and generative AI: L'Oréal launched the AI-powered HAPTA smart makeup stylus (designed for users with limited mobility), the energy-efficient infrared hair dryer AirLight Pro, and the generative AI beauty assistant Beauty Genius—achieving a strategic leap from 'Beauty for All' to 'Beauty for Each'. 2. Multipolar Brand Matrix Ecosystem (The Multipolar Brand Flotilla) L'Oréal has built a 'fleet' of 37 international brands spanning mass-market, luxury, dermatological/cosmeceutical, and professional haircare divisions—covering every price point and distribution channel. · A 'shock absorber' against market volatility: This multipolar model grants L'Oréal exceptional risk resilience. When growth slows in China’s luxury segment, its Dermatological Beauty division (featuring brands like La Roche-Posay, SkinCeuticals, and CeraVe) provides powerful momentum—generating over €7 billion in sales in 2024.

L'Oreal Taps Advisers to Explore Unloading Chemical-Related Liabilities, WSJ Reports

1 day ago

L'Oreal hired advisers to manage US legal liabilities concerning talc and chemical ingredients in cosmetics. The subsidiary faces mass lawsuits alleging illness while exploring options to unload these obligations.

reuters

2026-10-05

L'Oreal Taps Advisers to Explore Unloading Chemical-Related Liabilities, WSJ Reports

L'Oreal Taps Advisers to Explore Unloading Chemical-Related Liabilities, WSJ Reports

FAQ